131I-mIBG treatment dosimetry: dependence on the fitting expression and the role of biodosimetry

被引：0
|
作者：
Torres-Espallardo, I. [1 ]
Balaguer, J. [1 ]
Montoro, A. [1 ]
Sebastian, N. [1 ]
Loaiza, J. [1 ]
Olivas, C. [1 ]
Bautista, J. [1 ]
Adria, M. [1 ]
Ibanez, B. [1 ]
Pascual, V. [1 ]
Campayo, J. [1 ]
Villaescusa, J. [1 ]
Canete, A. [1 ]
Castel, V. [1 ]
Bello, P. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP496
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [31] Treatment planning for 131I-mIBG Radionuclide therapy of high-risk neuroblastoma based on patient-specific Dosimetry
    Buckley, S.
    Saran, F.
    Gaze, M.
    Hindorf, C.
    Chittenden, S.
    Lancaster, D.
    Pearson, A.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S179 - S179
  • [32] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Jose Genolla
    Trinidad Rodriguez
    Pablo Minguez
    Ricardo Lopez-Almaraz
    Veronica Llorens
    Aizpea Echebarria
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1567 - 1575
  • [33] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
  • [34] Nothing but NET: A Review of Norepinephrine Transporter Expression and Efficacy of 131I-mIBG Therapy
    Streby, Keri A.
    Shah, Nilay
    Ranalli, Mark A.
    Kunkler, Anne
    Cripe, Timothy P.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (01) : 5 - 11
  • [35] Sequelae and survivorship in patients treated with 131I-MIBG therapy
    W C C Sze
    A B Grossman
    I Goddard
    D Amendra
    S C C Shieh
    P N Plowman
    W M Drake
    S A Akker
    M R Druce
    British Journal of Cancer, 2013, 109 : 565 - 572
  • [36] Local delivery of 131I-MIBG to treat peritoneal neuroblastoma
    Kinuya, S
    Li, XF
    Yokoyama, K
    Mori, H
    Shiba, K
    Watanabe, N
    Shuke, N
    Bunko, H
    Michigishi, T
    Tonami, N
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) : 1246 - 1250
  • [37] Local delivery of 131I-MIBG to treat peritoneal neuroblastoma
    Seigo Kinuya
    Xiao-Feng Li
    Kunihiko Yokoyama
    Hirofumi Mori
    Kazuhiro Shiba
    Naoto Watanabe
    Noriyuki Shuke
    Hisashi Bunko
    Takatoshi Michigishi
    Norihisa Tonami
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1246 - 1250
  • [38] ANATOMIC PATTERNS OF RELAPSE AND PROGRESSION FOLLOWING TREATMENT WITH 131I-MIBG IN METASTATIC NEUROBLASTOMA
    Ben Kenan, Fishel R.
    Polishchuk, A.
    Haas-Kogan, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 143 - 143
  • [39] 131I-MIBG诊断嗜铬细胞瘤
    谢志淳
    林好学
    林军
    缪蔚冰
    吴可贵
    福建医科大学学报, 1997, (04) : 55 - 57
  • [40] 131I-MIBG肾上腺髓质显像方法探讨
    彭接权
    林好学
    谢志淳
    福建医药杂志, 2001, (05) : 145 - 146+203
12345